Company Information

  

Address: 98 SPIT BROOK ROAD, SUITE 100  
City: NASHUA 
State: NH 
Zip Code: 03062 
Telephone: 603-882-5200 

Description of Business

Primary SIC Code: 3841
(As filed with the SEC)  

iCAD, Inc. is a global medical technology leader providing innovative cancer detection and therapy solutions. The Company reports in two operating segments: Cancer Detection ("Detection") and Cancer Therapy ("Therapy"). The Company was incorporated in 1984 as Howtek, Inc. under the laws of the state of Delaware. In 2002 the Company changed its name to iCAD, Inc. and changed its ticker symbol to ICAD. The iCAD website is www.icadmed.com. On this website the following documents are available at no charge: annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended ("Exchange Act"), as soon as reasonably practicable after the Company electronically files such material with, or furnishes it to, the SEC.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
03/2018-1.04NAN/E
12/2017-0.87NAN/E
09/2017-0.82NAN/E
06/2017-0.56NAN/E
03/2017-0.50NAN/E
12/2016-0.63NAN/E
09/2016-0.58NAN/E
06/2016-0.43NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.07Total Liab/Total Assets0.56
Net Inc/Total Assets-0.44Total Liab/Inv Cap0.93
Net Inc/Inv Cap-0.74Total Liab/Comm Equity0.08
Pretax Inc/Net Sales-0.51Interest Coverage Ratio-114.11
Net Inc/Net Sales-0.51Curr Debt/Equity0.06
Cash Flow/Net Sales-0.26LTD/Equity0.36
SG&A/NetSales0.65Total Debt/Equity0.42
Asset Utilization   Liquidity  
Net Receivables Turnover4.08Quick Ratio1.58
Inventory Turnover3.39Current Ratio1.76
Inventory Day Sales0.01Net Rec/Curr Assets0.41
Net Sales/Work Cap3.07Inv/Curr Assets0.10
Net Sales/PP&E48.79  

Income Statement (Millions)

  3/31/2018 12/31/2017 9/30/2017 6/30/2017
Total Revenues(Net Sales) 6.31 7.90 7.00 6.41
Cost of Goods Sold 1.82 3.56 2.36 1.91
Selling & Admin Exps 4.22 4.14 4.52 4.78
Operating Income -3.15 -4.17 -6.94 -2.62
Interest Exp 0.14 0.07 0.04 0.01
Pretax Income -3.27 -4.23 -6.98 -2.63
Other Income 0.02 0.02 0.00 0.00
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -3.28 -4.24 -6.93 -2.63

Balance Sheet (Millions)

Assets 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Cash & Short Term Investments 8.66 9.39 11.26 7.68
Receivables - Total 7.28 8.60 7.19 5.48
Inventories - Total 2.20 2.12 3.34 3.48
Total Current Assets 19.30 21.21 22.74 17.06
Net Property, Plant & Equipment 0.50 0.58 0.97 1.14
Total Assets 30.05 32.13 35.95 35.62
Liabilities        
Accounts Payable 6.23 5.84 6.28 5.43
Debt in Current Liabilities 1.20 0.83 0.33 0.00
Total Current Liabilities 12.90 12.07 11.63 10.52
Long-Term Debt 4.83 5.15 5.64 NA
Total Liabilities 18.61 17.86 17.95 11.19
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.17 0.17 0.17 0.17
Retained Earnings -205.04 -201.87 -197.63 -190.70
Treasury Stock -1.42 -1.42 -1.42 -1.42
Total Stockholders' Equity 11.44 14.28 18.00 24.43
Total Liabilities and Stockholders' Equity 30.05 32.13 35.95 35.62

Cash Flow Summary (Millions)

Categories 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Net Cash Provided by Operating Activities -0.64 -1.77 -2.32 -1.64
Net Cash Provided by Investing Activities -0.02 -0.03 -0.03 -0.08
Net Cash Provided by Financing Activities -0.06 -0.07 5.92 -0.14

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201333.07-7.61-0.70
12/201443.92-1.01-0.07
12/201541.55-32.45-2.07
12/201626.34-10.10-0.63
12/201728.10-14.26-0.87
Growth Rates-3.99----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/18363,16018.97




Report Date : 7/16/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.